Olympus Corporation
Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting… Read more
Olympus Corporation (OLYMY) - Total Assets
Latest total assets as of September 2025: $1.38 Trillion USD
Based on the latest financial reports, Olympus Corporation (OLYMY) holds total assets worth $1.38 Trillion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Olympus Corporation - Total Assets Trend (2003–2025)
This chart illustrates how Olympus Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Olympus Corporation - Asset Composition Analysis
Current Asset Composition (March 2025)
Olympus Corporation's total assets of $1.38 Trillion consist of 47.4% current assets and 52.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.6% |
| Accounts Receivable | $204.18 Billion | 14.3% |
| Inventory | $187.15 Billion | 13.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $93.97 Billion | 6.6% |
| Goodwill | $180.19 Billion | 12.6% |
Asset Composition Trend (2003–2025)
This chart illustrates how Olympus Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Olympus Corporation's current assets represent 47.4% of total assets in 2025, a decrease from 59.0% in 2003.
- Cash Position: Cash and equivalents constituted 17.6% of total assets in 2025, up from 16.9% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 0.0% in 2003.
- Asset Diversification: The largest asset category is accounts receivable at 14.3% of total assets.
Olympus Corporation Competitors by Total Assets
Key competitors of Olympus Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Olympus Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Olympus Corporation generates 0.70x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Olympus Corporation generates $8.23 in net profit.
Olympus Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.06 | 1.57 | 1.88 |
| Quick Ratio | 1.35 | 1.12 | 1.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $310.93 Billion | $ 237.49 Billion | $ 267.56 Billion |
Olympus Corporation - Advanced Valuation Insights
This section examines the relationship between Olympus Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.57 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -6.6% |
| Total Assets | $1.43 Trillion |
| Market Capitalization | $11.25 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Olympus Corporation's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Olympus Corporation's assets decreased by 6.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Olympus Corporation (2003–2025)
The table below shows the annual total assets of Olympus Corporation from 2003 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $1.43 Trillion | -6.61% |
| 2024-03-31 | $1.53 Trillion | +1.72% |
| 2023-03-31 | $1.51 Trillion | +11.07% |
| 2022-03-31 | $1.36 Trillion | +14.99% |
| 2021-03-31 | $1.18 Trillion | +16.28% |
| 2020-03-31 | $1.02 Trillion | +8.97% |
| 2019-03-31 | $932.03 Billion | -4.76% |
| 2018-03-31 | $978.66 Billion | -1.25% |
| 2017-03-31 | $991.06 Billion | -0.95% |
| 2016-03-31 | $1.00 Trillion | -7.48% |
| 2015-03-31 | $1.08 Trillion | +5.26% |
| 2014-03-31 | $1.03 Trillion | +7.02% |
| 2013-03-31 | $960.08 Billion | -0.67% |
| 2012-03-31 | $966.53 Billion | -9.13% |
| 2011-03-31 | $1.06 Trillion | -7.69% |
| 2010-03-31 | $1.15 Trillion | +4.15% |
| 2009-03-31 | $1.11 Trillion | -18.55% |
| 2008-03-31 | $1.36 Trillion | +24.41% |
| 2007-03-31 | $1.09 Trillion | +11.85% |
| 2006-03-31 | $976.13 Billion | +13.76% |
| 2005-03-31 | $858.08 Billion | +25.69% |
| 2004-03-31 | $682.67 Billion | +12.70% |
| 2003-03-31 | $605.77 Billion | -- |